cio.economictimes.indiatimes1mon
Nvidia-backed AI firm Iambic unveils drug discovery 'breakthrough'
Biotech firm Iambic Therapeutics unveiled on Tuesday what it says is a breakthrough artificial intelligence model that could drastically reduce the time and money needed to develop new drugs.
NDTV1mon
Nvidia-Backed AI Firm Unveils Drug Discovery "Breakthrough"
Biotech firm Iambic Therapeutics unveiled on Tuesday what it says is a breakthrough artificial intelligence model that could drastically reduce the time and money needed to develop new drugs.
Yahoo1mon
Nvidia-backed AI firm Iambic unveils drug discovery ‘breakthrough’
LONDON (Reuters) - Biotech firm Iambic Therapeutics unveiled on Tuesday what it says is a breakthrough artificial intelligence model that could drastically reduce the time and money needed to ...
ENDPOINTS NEWS1mon
Iambic at­tempts to ‘break the wall’ be­tween the lab and clin­ic with new AI mod­el
Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Business Wire1mon
Iambic Therapeutics Announces “Enchant,” an AI Platform that Predicts Clinical Outcomes from the Earliest Stages of Drug Discovery
SAN DIEGO--(BUSINESS WIRE)--Iambic Therapeutics, a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, today announced Enchant™, a ...
Yahoo Finance1mon
Iambic Therapeutics Announces "Enchant," an AI Platform that Predicts Clinical Outcomes from the Earliest Stages of Drug Discovery
Enchant provides Iambic’s scientists a new in silico tool to reduce clinical risk by predicting the viability of molecules from the earliest stage of drug discovery programs. These predictions ...